Open AccessMolecular testing for BRAFV600E and RAS mutations from cytoscrapes of thyroid fine needle aspirates: A single-center pilot study
Author(s) -
Ojas Gupta,
Upasana Gautam,
Muralidaran Chandrasekhar,
Arvind Rajwanshi,
Bishan Dass Radotra,
Roshan Verma,
Radhika Srinivasan
Publication year - 2020
Publication title -
journal of cytology/journal of cytology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.267
H-Index - 19
eISSN - 0974-5165
pISSN - 0970-9371
DOI - 10.4103/joc.joc_45_20
Subject(s) - hras , neuroblastoma ras viral oncogene homolog , kras , medicine , v600e , thyroid carcinoma , thyroid cancer , thyroid , fine needle aspiration , pathology , cancer , biopsy , mutation , biology , colorectal cancer , gene , biochemistry
Molecular testing of thyroid FNA has been advocated in the indeterminate categories of The Bethesda System for Reporting Thyroid Cytopathology (TBSRTC) 2018. The utility of cytoscrapes of thyroid FNA samples for BRAF V600E and RAS mutations was evaluated in this pilot study.